A multicenter randomized controlled effectiveness trial of transdiagnostic treatment for adolescents with subthreshold anxiety and depressive symptoms
4 affiliations
- 1Universidad of La Rioja, Spain
- 2Universidad of Oviedo, Spain
- 3Universitat of Valencia, Spain
- 4Universite of Geneve, Switzerland
Abstract
Background: Depression and anxiety disorders and symptoms are among the leading causes of disability and global disease burden in young people. Scalable, unified interventions are required to address subthreshold emotional symptoms in adolescents as a preventive strategy. This study evaluated the effectiveness of a transdiagnostic treatment for adolescents with subthreshold emotional symptoms.
Methods: A multicenter, two-arm, randomized controlled trial was conducted. The Unified Protocol for Adolescents (UP-A) was compared with an active control consisting of protocolized progressive relaxation. A total of 676 adolescents (72.6% female; M age = 13.77; SD = 1.39; range = 12–18 years) participated in the study. Primary outcomes were self-reported depressive and anxiety symptoms at postintervention, 6 months, and 12 months. The trial is registered with ClinicalTrials.gov (NCT05322642).
Results: Three hundred seventy-eight participants were allocated to the UP-A group and 298 to the control group. Adherence was high in both conditions (≈78% attended >70% of sessions). Both interventions showed significant reductions in depressive and anxiety symptoms over time, with no significant between-group differences. At 12 months, the UP-A group showed marginally lower depressive symptoms and neuroticism. Significant treatment effects favoring the UP-A were observed for hyperactivity, conduct problems, and total mental health difficulties. Improvements were maintained across most outcomes at both follow-ups.
Conclusions: The comparable improvements observed across both conditions suggest that structured, group-based school interventions may help reduce emotional symptoms in adolescents with subthreshold presentations, rather than reflecting the superiority of a specific protocol. These findings support their potential for broad dissemination within stepped-care frameworks and for enhancing accessibility and real-world effectiveness of evidence-based treatments.
Related
- Identity-Based Transdiagnostic Therapy (IBTT) for young people with anxiety and depression: A study protocol for a multicenter randomized clinical trial
- Teacher-delivered transdiagnostic child mental healthcare in rural Indian primary schools (Tealeaf): study protocol for a batched stepped-wedge cluster randomized controlled trial with a hybrid effectiveness-implementation-context design.
- Effectiveness of a pharmacist-led protocol to manage cystitis in women, in France: the PharmaCyst’ open-label, multicenter, randomized, controlled, cluster study
- Effectiveness of facilitator-driven and peer-led educational interventions on tobacco use intention among adolescents: a school-based cluster randomized trial protocol
- Effectiveness of hochuekkito for colorectal cancer management: protocol for the multicenter randomized controlled AMATERAS study.
BibTeX
@article{fonsecapedrero2026multicenter,
title = {{A multicenter randomized controlled effectiveness trial of transdiagnostic treatment for adolescents with subthreshold anxiety and depressive symptoms}},
author = {Eduardo Fonseca-Pedrero and Alfonso Pérez-Esteban and Adriana Díez-Gómez and Alicia Pérez-Albéniz and Susana Al-Halabí and Beatriz Lucas-Molina and Martin Debbané},
journal = {Psychological Medicine},
year = {2026},
month = sep,
doi = {10.1017/s0033291726105443},
url = {https://doi.org/10.1017/s0033291726105443},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A multicenter randomized controlled effectiveness trial of transdiagnostic treatment for adolescents with subthreshold anxiety and depressive symptoms
AU - Eduardo Fonseca-Pedrero
AU - Alfonso Pérez-Esteban
AU - Adriana Díez-Gómez
AU - Alicia Pérez-Albéniz
AU - Susana Al-Halabí
AU - Beatriz Lucas-Molina
AU - Martin Debbané
PY - 2026
DA - 2026/09/04
JO - Psychological Medicine
DO - 10.1017/s0033291726105443
UR - https://doi.org/10.1017/s0033291726105443
AB - Background: Depression and anxiety disorders and symptoms are among the leading causes of disability and global disease burden in young people. Scalable, unified interventions are required to address subthreshold emotional symptoms in adolescents as a preventive strategy. This study evaluated the effectiveness of a transdiagnostic treatment for adolescents with subthreshold emotional symptoms. Methods: A multicenter, two-arm, randomized controlled trial was conducted. The Unified Protocol for Adolescents (UP-A) was compared with an active control consisting of protocolized progressive relaxation. A total of 676 adolescents (72.6% female; M age = 13.77; SD = 1.39; range = 12–18 years) participated in the study. Primary outcomes were self-reported depressive and anxiety symptoms at postintervention, 6 months, and 12 months. The trial is registered with ClinicalTrials.gov (NCT05322642). Results: Three hundred seventy-eight participants were allocated to the UP-A group and 298 to the control group. Adherence was high in both conditions (≈78% attended >70% of sessions). Both interventions showed significant reductions in depressive and anxiety symptoms over time, with no significant between-group differences. At 12 months, the UP-A group showed marginally lower depressive symptoms and neuroticism. Significant treatment effects favoring the UP-A were observed for hyperactivity, conduct problems, and total mental health difficulties. Improvements were maintained across most outcomes at both follow-ups. Conclusions: The comparable improvements observed across both conditions suggest that structured, group-based school interventions may help reduce emotional symptoms in adolescents with subthreshold presentations, rather than reflecting the superiority of a specific protocol. These findings support their potential for broad dissemination within stepped-care frameworks and for enhancing accessibility and real-world effectiveness of evidence-based treatments.
SN - 0033-2917
SN - 1469-8978
ER -